Scade tra 100 giorni Bando europeo
Integrating climate-related exposures into the human exposome and characterising its changes in response to climate change
Pubblicato dalla Commissione europea
Integrating climate-related exposures into the human exposome and characterising its changes in response to climate change è un bando europeo del programma Horizon Europe, gestito dalla Commissione europea o da una sua agenzia (codice HORIZON-HLTH-2027-01-ENVHLTH-02). Il budget del bando è di 45 milioni di euro, per circa 4 progetti. Per ogni progetto: da 10 a 11 milioni di euro. Scade il 17 febbraio 2027: le proposte si presentano dal 29 ottobre 2026 al 17 febbraio 2027.
Le cose da sapere
Dalla scheda della fonte ufficiale: fa fede l'avviso dell'ente.
- Programma
- Horizon Europe
- Area di Horizon Europe
- Salute
- Codice del bando
- HORIZON-HLTH-2027-01-ENVHLTH-02
- Call
- HORIZON-HLTH-2027-01 - Cluster 1 - Health (Single stage - 2027/1)
- Tipo di azione
- HORIZON Research and Innovation Actions
- Come si partecipa
- Una fase: si presenta la proposta completa
- Apertura
- 29 ottobre 2026
- Scadenza
- 17 febbraio 2027
- Budget del bando
- 45 milioni di euro (2027)
- Progetti finanziati
- circa 4
- Contributo per progetto
- Da 10 a 11 milioni di euro
- Aggiornato dalla fonte
- 29 ottobre 2026
La descrizione ufficiale
Il testo del portale della Commissione europea, in inglese come l'originale.
Leggi tutta la descrizione
Expected Outcome
This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Living and working in a health-promoting environment”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to most of the following expected outcomes:
- Researchers, policymakers, healthcare practitioners and the public have a more comprehensive understanding of the human exposome and the interactions between climatic, environmental and socio-behavioural factors, supported by FAIR[1] data linking these exposures to disease and health outcomes.
- Researchers, governments, policymakers, social care services and healthcare practitioners have improved knowledge on the links between the climatic, social, lifestyle and environmental factors of the exposome and global health burden, supporting their efforts to adopt the exposome approach to identify and address relevant health impacts.
- The public has access to the latest information on the influence of global environmental exposures on health, enabling the adoption of health-promoting, climate-resilient and nature-positive behaviours.
Scope
The exposome is the totality of exposures (and their interactions) experienced by an individual throughout their lifetime, including chemical, physical, biological, nutritional and psychosocial factors, from conception onwards. Many of these factors originate in the environment, including climate-related exposures such as extreme heat, heightened air pollution or drought. Climate change may amplify or interact synergistically with other better-established exposures, dynamically altering the human exposome and its health implications. Despite this, climate factors remain underrepresented in large-scale human exposome studies.
Research activities under this topic should strengthen the use of the exposome approach to study global exposures and generate evidence on their health implications. Proposals should focus on integrating climate-related factors into exposome research and understanding how the exposome changes in response to direct and indirect climate exposures. Moreover, research activities should be multiscale and multidisciplinary and account for the complexity and multifactorial nature of health determinants and the most pressing unmet medical needs in relation to environmental degradation and disrupted ecosystems. Proposals should include climate-relevant social determinants of health as part of their proposed activities.
More specifically, research actions under this topic should include all the following activities:
- Incorporate multiple climate exposures into exposomics studies and provide insights on their influence on disease burden, through interactions with other exposome factors.
- Predict, identify and monitor changes in the exposome (including environmental, social and occupational exposures) resulting from climate-related pressures and study their health implications to identify emerging health risks and potential benefits of climate change.
- Advance data generation, analysis, integration and interpretation in human exposomics, developing methodologies and integrating novel approaches (e.g. AI technologies and machine learning) for advanced data analytics, including for Real-World Data (RWD)[2].
In addition, research actions should include several of the following targeted activities:
- Establish and investigate the biological pathways and mechanisms by which the exposome drives health impacts, jointly considering climate-related and other exposures. Build upon (when relevant) and study existing and/or newly generated longitudinal cohorts that combine individual exposome data with the corresponding medical, omics and biological data.
- Identify exposome-relevant indicators and biomarkers for exposome-related health risks and potential benefits using comprehensive exposome studies that combine climate, environmental, behavioural and social exposures. Account for disparities in individual trajectories and exposure patterns where relevant.
- Report on health-relevant exposome findings using, where possible, standardised metrics to ensure harmonised reporting of exposome-driven disease burden across regions and sectors. Build on existing exposome toolboxes and increase their robustness and coverage by integrating climate related exposures.
- Study the role of socioeconomic (e.g. income, energy poverty, occupation), demographic (e.g. gender, racial or ethnic origin[3], age) and behavioural (e.g. public trust, risk perception) factors in determining patterns of exposure, using the exposome approach to generate knowledge on intersectional vulnerability and resilience to exposome-driven (including climate-driven) health impacts. Identify disproportionately affected populations and develop interventions to reduce disparities.
When handling vulnerability data and indicators, sex-, gender-, racial or ethnic origin[3]-disaggregated data should be collected and analysed, incorporating intersectional factors where feasible and relevant.
International cooperation is encouraged, in particular with regions that are under-represented in human exposome research.
Projects should leverage the knowledge, data and tools already generated under past initiatives such as EHEN[5] and ongoing initiatives such as IHEN[6], ICOS ERIC[7] and EIRENE RI[8].
Proposals are encouraged to consider, where relevant, the data, expertise and services offered by European research infrastructures[9] in the environment, climate and health domain. Projects should make the tools developed as part of their research available on the IHEN Exposome Toolbox[10] and upload their data sets in the IHEN Data Catalogue[11].
In order to maximise synergies and increase the impact of the projects, all proposals selected for funding from this topic will form a cluster and be required to participate in common networking and joint activities. Guidance on the potential activities to be developed can be obtained by consulting the ongoing clusters of projects under the Environment, Climate and Health research portfolio[12].
Proposals should make sure that relevant activities, outcomes and outputs are shared with the European Climate and Health Observatory[13] through the cluster that will be formed after the approval of the proposals.
This topic requires the effective contribution of social sciences and humanities (SSH) disciplines and the involvement of SSH experts, institutions as well as the inclusion of relevant SSH expertise, in order to produce meaningful and significant effects enhancing the societal impact of the related research activities.
Applicants envisaging to include clinical studies[14] should provide details of their clinical studies in the dedicated annex using the template provided in the submission system.
[1] See definition of FAIR data in the introduction to this Work Programme part.
[2] EMA definition: “Real-World Data are routinely collected data relating to patient health status or the delivery of healthcare from a variety of sources other than traditional clinical trials (e.g. claims databases, hospital data, electronic health records, registries, mhealth data, etc.)”.
[3] The use of the term ‘racial or ethnic origin’ does not imply an acceptance of theories that attempt to determine the existence of separate human races.
[4] The use of the term ‘racial or ethnic origin’ does not imply an acceptance of theories that attempt to determine the existence of separate human races.
[5] https://www.humanexposome.eu
[7] https://www.icos-cp.eu/about/organisation-governance/icos-eric
[9] The catalogue of European Strategy Forum on Research Infrastructures (ESFRI) research infrastructures portfolio can be browsed on the ESFRI website: https://ri-portfolio.esfri.eu
[10] https://bio.tools/t?domain=exposome
[11] https://data-catalogue.molgeniscloud.org/catalogue/catalogue
[12] https://research-and-innovation.ec.europa.eu/research-area/health/environment-climate-and-health_en
[13] https://climate-adapt.eea.europa.eu/en/observatory
[14] Please note that the definition of clinical studies (see introduction to this Work Programme part) is broad and it is recommended that you review it thoroughly before submitting your application.
Fonte: portale Funding & Tenders della Commissione europea , © Unione europea, licenza CC BY 4.0 .
Documenti ufficiali
La fonte non elenca documenti: li trovi sulla pagina ufficiale del bando. Apri la pagina ufficiale
Domande su questo bando
Quando scade?
Scade il 17 febbraio 2027: le proposte si presentano dal 29 ottobre 2026 al 17 febbraio 2027.
Quanto si può ottenere?
Il contributo per ogni progetto va da 10 a 11 milioni di euro. Il budget complessivo del bando è di 45 milioni di euro, per circa 4 progetti.
È a fondo perduto?
Sì: i bandi della Commissione europea danno contributi che non si restituiscono, di solito una parte dei costi del progetto, versata in più rate durante il progetto.
Dove si presenta la domanda?
Sul portale Funding & Tenders della Commissione europea, con un account EU Login. In questa scheda trovi il link alla pagina ufficiale del bando e ai suoi documenti.
Fonte: portale Funding & Tenders della Commissione europea. Controllato da Bandabando il 30 ottobre 2026.
Bandabando riassume le informazioni pubbliche per aiutarti a orientarti: fa sempre fede l'avviso ufficiale dell'ente. Come lavoriamo: fonti e metodo.
Fa per la tua impresa?
Il Capobanda è l'assistente di Bandabando: legge l'avviso al posto tuo e ti risponde con la fonte.
- Controlla i requisiti sulla tua impresa
- Ti dice quanto puoi chiedere e per quali spese
- Prepara l'elenco dei documenti della domanda
Gratis. Accedi con Google, Microsoft o la tua email.
Non perderlo di vista
Bandi simili
Aperti o in arrivo, scelti per territorio e tema.
- Addressing disabilities through the life course to support independent living and inclusion Scade il 17 febbraio 2027. Scade tra 100 giorni
- Clinical trials for advancing innovative interventions for neurodegenerative diseases Scade il 17 febbraio 2027. Scade tra 100 giorni
- Development of cell-free protein synthesis platforms for discovery and/or production of biologicals Scade il 17 febbraio 2027. Scade tra 100 giorni
- Development of innovative antimicrobials against pathogens resistant to antimicrobials Scade il 17 febbraio 2027. Scade tra 100 giorni
- Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses Scade il 17 febbraio 2027. Scade tra 100 giorni
- Development of monoclonal antibodies to prevent and treat infections from Flaviviruses Scade il 17 febbraio 2027. Scade tra 100 giorni